Overview
David Sidransky is an Oncologist and an Otolaryngologist in Baltimore, Maryland. Dr. Sidransky is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Adenoid Cystic Carcinoma, Salivary Gland Tumors, and Polymorphous Low Grade Adenocarcinoma.
His clinical research consists of co-authoring 182 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Polymorphous Low Grade Adenocarcinoma.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Outpatient Center
Head and neck surgeon David Eisele specializes in surgery for malignant and benign tumors of the head and neck, with a focus on salivary gland neoplasms and disorders of the salivary glands that can be treated surgically. He is an expert in minimally invasive surgical approaches, including sialendoscopy. Salivary gland neoplasms and disorders are also the focus of Dr. Eisele’s research. He has published more than 300 research papers and edited multiple books related to head and neck surgery. Dr. Eisele earned a medical degree from Cornell University Medical College and completed residency training in general surgery and in otolaryngology–head and neck surgery at the University of Washington. From 2012 to 2025, he served as director of the Department of Otolaryngology–Head and Neck Surgery at the Johns Hopkins University School of Medicine. Dr. Eisele is rated as an Elite provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Salivary Duct Stones, Salivary Gland Tumors, Throat Cancer, Laryngectomy, and Gastrostomy.
Johns Hopkins University
Dr. Tanguy Seiwert is an oncologist in Baltimore, caring for patients with head and neck cancer. He serves as the director of the Head and Neck Cancer Oncology Disease Program and the co-director of the Bloomberg~Kimmel Institute for Immunotherapy at the Head and Neck Cancer Program at the Johns Hopkins School of Medicine. Dr. Seiwert earned his M.D. at Johannes Gutenberg Universität in Mainz, Germany. He completed his residency at the Duke University School of Medicine and performed a fellowship in hematology/oncology at the University of Chicago Medicine Mitchell Hospital-Hyde Park. Dr. Seiwert joined the Johns Hopkins faculty in 2019. Prior to joining Johns Hopkins, Dr. Seiwert was director of the Head and Neck Cancer Program at the University of Chicago. Dr. Seiwert’s research interests include immunologic and genomic profiling. He has given numerous invited talks on head and neck cancer both nationally and internationally. Dr. Seiwert served as chief editor for Frontiers in Head and Neck Cancer and as an editorial board member for the Journal of Clinical Oncology and Oral Oncology. He is a reviewer for multiple medical journals, including Lancet Oncology, Annals of Oncology and Clinical Cancer Research. He has been recognized by the American Association for Clinical Oncology for multiple Merit Awards and a Young Investigator Award. He was a member of the NCI Head and Neck Cancer Steering Committee, and is a member of the American Association for Clinical Oncology, the Society for Immunotherapy of Cancer, and the European Society of Clinical Oncology. Dr. Seiwert is rated as an Advanced provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Glioma, Laryngeal Cancer, Tongue Cancer, Oral Squamous Cell Carcinoma, and Gastrostomy.
ENT & Allergy Of Delaware
Neil Hockstein is an Otolaryngologist in Newark, Delaware. Dr. Hockstein has been practicing medicine for over 26 years and is rated as a Distinguished provider by MediFind in the treatment of Polymorphous Low Grade Adenocarcinoma. His top areas of expertise are Salivary Gland Tumors, Acinic Cell Carcinoma of Salivary Glands, Laryngeal Cancer, Laryngectomy, and Thyroidectomy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Distinguished
- Adenoid Cystic CarcinomaDr. Sidransky isDistinguished. Learn about Adenoid Cystic Carcinoma.
- Salivary Gland TumorsDr. Sidransky isDistinguished. Learn about Salivary Gland Tumors.
- Advanced
- Bladder CancerDr. Sidransky isAdvanced. Learn about Bladder Cancer.
- Cervical CancerDr. Sidransky isAdvanced. Learn about Cervical Cancer.
- Gallbladder AdenocarcinomaDr. Sidransky isAdvanced. Learn about Gallbladder Adenocarcinoma.
- Lung CancerDr. Sidransky isAdvanced. Learn about Lung Cancer.
- Polymorphous Low Grade AdenocarcinomaDr. Sidransky isAdvanced. Learn about Polymorphous Low Grade Adenocarcinoma.
- Urothelial CancerDr. Sidransky isAdvanced. Learn about Urothelial Cancer.
- Experienced
- Brain TumorDr. Sidransky isExperienced. Learn about Brain Tumor.
- Breast CancerDr. Sidransky isExperienced. Learn about Breast Cancer.
- Colorectal CancerDr. Sidransky isExperienced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerDr. Sidransky isExperienced. Learn about EGFR Positive Lung Cancer.
- Esophageal CancerDr. Sidransky isExperienced. Learn about Esophageal Cancer.
- Gallbladder CancerDr. Sidransky isExperienced. Learn about Gallbladder Cancer.


